Device Trial Radar · NCT03056222
CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Nov 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
360
Actual
Start
Apr 10, 2017
Primary completion
Aug 16, 2021
Study completion Nov 15, 2021
Sponsor
- Lead sponsor
- I-Med-Pro GmbHAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 17, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to compare the acute procedure and safety outcomes as well as long term clinical outcomes of 2 groups of patients treated with the HeartLight® Endoscopically Guided Laser Ablation (EGLA) or a commercially available Contact Force Sensing Irrigated Radiofrequency (RF) Ablation Catheter plus, at the operator's discretion, 3D Electroanatomical Mapping (EAM) for the treatment of Paroxysmal Atrial Fibrillation (PAF).
Conditions
- Paroxysmal Atrial Fibrillation
Interventions
Ablation catheterDevice
Ablation of paroxysmal atrial fibrillation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from symptomatic, recurrent atrial fibrillation (AF) off of anti-arrhythmic drugsTime frame: 12 months post procedure
Locations
11 sites in 4 countries. Site status is shown where the registry gives one.
Hartcentrum OLV Aalst
Aalst, Belgium
Hartcentrum Hasselt Jessa Ziekenhuis
Hasselt, Belgium
Nemocnice Na Homolce
Prague, Czechia
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.